Delivery Order SPE2DB22D1052-SPE2DB25FU9PD
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,741.30 to AmerisourceBergen Drug Corp for Hydrocort-Pramoxine 1%-1% cream in 30-gram units. The contract was competitively awarded with no set-aside designation and carries a firm fixed price structure with an ultimate completion date of July 28, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime...
- The Defense Logistics Agency awarded a $1,278.46 delivery order to AmerisourceBergen Drug Corp for Hydrocortisone-Pramoxine 2.5-1% cream in a 30-gram size on August 15, 2025, with an ultimate completion date of August 18, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for...
- The Defense Logistics Agency awarded a $3,778.36 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Hydrocort-Pramoxine 2.5-1% cream (28.4 grams) on August 27, 2025, with completion targeted for August 28, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was not set-aside and was competitively awarded....
- The Defense Logistics Agency awarded a delivery order valued at $1,464.46 to AmerisourceBergen Drug Corp for Hydrocortisone-Pramoxine 2.5-1% cream in 30-gram units. This firm fixed price delivery order, issued on August 6, 2025, with an ultimate completion date of August 7, 2025, represents a small-value pharmaceutical procurement supporting federal medical supply needs. The award was competitively awarded with no set-aside designation and will be performed at the contractor's facility in...
- The Defense Logistics Agency awarded a $3,622.98 delivery order to AmerisourceBergen Drug Corp for Hydrocort-Pramoxine 2.5-1% cream in 30-gram units, with an ultimate completion date of July 28, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is being performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's larger contract vehicle with the Defense Logistics...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Hydrocort-Pramoxine 2.5-1% cream in a 30-gram quantity, with a ceiling value of $3,264.15. This is a firm fixed-price delivery order with an ultimate completion date of September 3, 2025, and performance to be executed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this award, indicating it was competitively...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide a pharmaceutical product - Hydrocort-Pramoxine 2.5-1% Cream 30GM. The $2,002.93 contract has an ultimate completion date of April 12, 2024. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp to deliver a comprehensive range of...
- This is a $1,434.24 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Hydrocortisone-Pramoxine 2.5-1% cream. The order has a completion date of September 18, 2024. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) valued up to $999,999,999 with the DLA Troop Support Medical through December 2025 for delivering a wide range of medical commodities to support military...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,223.10 firm fixed-price contract is for the supply of Hydrocort-Pramoxine 2.5-1% Cream, 30 grams, with a period of performance through November 19, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,890.84 firm fixed-price contract is for the delivery of Hydrocort-Pramoxine 2.5-1% Cream, a topical medication, with a period of performance through May 8, 2023. The contract award is not designated as a set-aside. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with...
- SPE2DB22D1052Indefinite Delivery Contract
- SPE2DB22D1052-SPE2DB25FU9PDDelivery Order
The Defense Logistics Agency awarded a $1,962.45 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Hydrocort-Pramoxine 1%-1% Cream, 30 gram units, with an ultimate completion date of July 17, 2025. This is a non-set-aside contract, indicating it was awarded through open competition. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement needs, particularly supporting military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The parent IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The topical corticosteroid-anesthetic cream being procured represents one of many pharmaceutical products distributed through this contract vehicle to support Defense Health Agency and other federal healthcare system requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 7/16/25 |